QCovid® was used by the NHS in 2021 to identify patients in England at high risk of severe COVID-19 outcomes, adding an additional 1.7 million people to the national shielded patient list and informing vaccine prioritisation.
Robust tool, shows excellent performance in identifying patients most at risk of severe COVID-19
QCovid v1-3 has been independently externally validated in England, Wales and Scotland
Calculates cumulative absolute risk associated with multiple co-morbidities, age, prior infection, and vaccination status
Latest version (QCovid4) considers previous infection and vaccination status
Provides a combined individualised risk prediction measure which can be used to better inform clinical decision-making
Based on very large population data sources that have been used to develop other, widely-used risk prediction tools
More accurately identifies patients at the highest absolute risk levels, so can be used to target COVID-19 therapies, and clinical trial patient selection